Cargando…

Hypertension among persons living with HIV—Zambia, 2021; A cross-sectional study of a national electronic health record system

Hypertension is a major risk factor for cardiovascular disease, which is a common cause of death in Zambia. Data on hypertension prevalence in Zambia are scarce and limited to specific geographic areas and/or populations. We measured hypertension prevalence among persons living with HIV (PLHIV) in Z...

Descripción completa

Detalles Bibliográficos
Autores principales: Hines, Jonas Z., Prieto, Jose Tomas, Itoh, Megumi, Fwoloshi, Sombo, Zyambo, Khozya D., Sivile, Suilanji, Mweemba, Aggrey, Chisemba, Paul, Kakoma, Ernest, Zachary, Dalila, Chitambala, Cecilia, Minchella, Peter A., Mulenga, Lloyd B., Agolory, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10332593/
https://www.ncbi.nlm.nih.gov/pubmed/37428721
http://dx.doi.org/10.1371/journal.pgph.0001686
Descripción
Sumario:Hypertension is a major risk factor for cardiovascular disease, which is a common cause of death in Zambia. Data on hypertension prevalence in Zambia are scarce and limited to specific geographic areas and/or populations. We measured hypertension prevalence among persons living with HIV (PLHIV) in Zambia using a national electronic health record (EHR) system. We did a cross-sectional study of hypertension prevalence among PLHIV aged ≥18 years during 2021. Data were extracted from the SmartCare EHR, which covers ~90% of PLHIV on treatment in Zambia. PLHIV with ≥2 clinical visits in 2021 were included. Hypertension was defined as ≥2 elevated blood pressure readings (systolic ≥140 mmHg/diastolic ≥90 mmHg) during 2021 and/or on anti-hypertensive medication recorded in their EHR ≤5 years. Logistic regression was used to assess for associations between hypertension and demographic characteristics. Among 750,098 PLHIV aged ≥18 years with ≥2 visits during 2021, 101,363 (13.5%) had ≥2 recorded blood pressure readings. Among these PLHIV, 14.7% (95% confidence interval [CI]: 14.5–14.9) had hypertension. Only 8.9% of PLHIV with hypertension had an anti-hypertensive medication recorded in their EHR. The odds of hypertension were greater in older age groups compared to PLHIV aged 18–29 years (adjusted odds ratio [aOR] for 30–44 years: 2.6 [95% CI: 2.4–2.9]; aOR for 45–49 years: 6.4 [95% CI: 5.8–7.0]; aOR for ≥60 years: 14.5 [95% CI: 13.1–16.1]), urban areas (aOR: 1.9 [95% CI: 1.8–2.1]), and on ART for ≥6-month at a time (aOR: 1.1 [95% CI: 1.0–1.2]). Hypertension was common among PLHIV in Zambia, with few having documentation of treatment. Most PLHIV were excluded from the analysis because of missing BP measurements. Strengthening integrated management of non-communicable diseases in HIV clinics might help to diagnose and treat hypertension in Zambia. Addressing missing data of routine clinical data (like blood pressure) could improve non-communicable diseases surveillance in Zambia.